Drawing for AAAH WILLNESS PROGRAM

USPTO serial 85148384

AAAH WILLNESS PROGRAM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CASE, LEIGH CAROLINE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AAAH WILLNESS PROGRAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lynn A. Sullivan

LYNN A. SULLIVAN LEYDIG VOIT & MAYER, LTD.2 PRUDENTIAL PLAZA 180 N STETSONSTE 490CHICAGO, IL 60601

Goods and services

ClassDescriptionStatusFirst use
009Software and hardware for the integration of health data from patients, providers and payers; computer hardware and software used to gather and search data in real time for use in medical research and for healthcare services; Computer software and hardware for the integration of personal, entertainment, security and health information by means of sending, receiving, recording, searching, storing, processing, manipulating and transmitting of information, data, voice messages, text, images, sound recordings and documents that relate to the personal, entertainment, security and health information of the particular user; Computer software and hardware for the integration of personal, entertainment, security and health electronic apparatus and equipmentACTIVE—
035Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare for developing, testing and validating next-generation diagnostics and pharmaceuticals to target pre-selected patients based on molecular profiles to predict drug response to particular therapeutics; promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; health care cost review and cost containment services; electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; business services provided to the medicine and healthcare industries, namely, the collection, reporting and analysis of healthcare quality data for business purposes; data processing services in the fields of medicine and healthcare; services consisting of the registration, collection, transcription, compilation and systemization of written communications and data in the fields of medicine and healthcare; providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; services comprising the recording, transcription, composition, compilation and systematization of health and medical communications and recordings, as well as compilation of related mathematical or statistical dataACTIVE—
042Information technology and data services, namely, integration of computer systems and networks; computer services, namely, design and development of searchable databases of information and data that allow the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of health and medical data and generation of reports thereof; providing use of a non-downloadable web based software application to ensure selection of and reimbursement for appropriate treatments for illnesses and to reduce cost and unnecessary utilization in the treatment of critical illnesses, to provide medical information between providers, subscribers and insurers; creating an online community for registered users to participate in discussions, get feedback from others, engage in networking featuring topics on the media, health care and fitness; research and development of next generation diagnostics and therapeutics tailored to specific molecular profiling of patient tissues and treatments for critical illnessesACTIVE—
044Providing an interactive computer database in the healthcare field that integrates patient data, bioinformatics, discovery research, molecular medicine and clinical developments designed to match patients with their personalized treatment regimens and preferred healthcare providers; providing a website featuring audio, video, photographic and prose presentations regarding healthcare and medical services; providing medical information, consultancy and advisory servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 18, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 18, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 8, 2011DOCKASSIGNED TO EXAMINER—
Nov 15, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 20, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 16, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 15, 2011ALIEASSIGNED TO LIE—
Jul 30, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 30, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Jul 30, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 30, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 30, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 19, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 19, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2011DOCKASSIGNED TO EXAMINER—
Oct 13, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 12, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance